Where does Rajesh Devraj work?

Rajesh Devraj is Venture Partner at Atlas Venture.

What check size does Rajesh Devraj write?

Rajesh Devraj typically writes checks of $10M – $50M.

What boards does Rajesh Devraj sit on?

Rajesh Devraj holds tracked board seats at Antegrin Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.

What companies has Rajesh Devraj invested in?

Investments tracked here include Rectifypharma.

Rajesh Devraj

Investor

Venture Partner at Atlas Venture

Cambridge, Massachusetts

Writes $10M – $50M checks · typically $25M

Find your path to Rajesh

419 people in our graph can introduce you to Rajesh.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Samantha Truex to introduce you to Rajesh

You →Samantha · together at Padlock Therapeutics Inc. (2014–2016) →Rajesh

Ask Jamie Chen to introduce you to Rajesh

You →Jamie · 11 people · together at Searle Discovery Research, Monsanto Life Sciences, Co. →Rajesh

Your email: the people you already email who know Rajesh
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Rajesh
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Experience

Rectify PharmaceuticalsPresident & CEOcurrent2022 — presentCambridge, Massachusetts, United States
Washington University School of Medicine in St. LouisBiopharma Advisory Committeecurrent2023 — present
Euclises Pharmaceuticals Inc.Board Director2015 — 2025Greater St. Louis
Euclises Pharmaceuticals Inc.President and Chief Executive Officer2013 — 2014Greater St. Louis
Sail BIOBoard Director2021 — 2024Cambridge, Massachusetts, United States
Disarm TherapeuticsChief Scientific Officer and Co-founder2016 — 2020Cambridge, MA, USA
Indalo TherapeuticsBoard Director2017 — 2020Cambridge, Massachusetts, United States
Antegrin Therapeutics, LLCChairman of the Board of Managers2013 — 2016Greater St. Louis
Padlock Therapeutics Inc.Chief Scientific Officer2014 — 2016Cambridge, Massachusetts
Deciphera PharmaceuticalsScientific Advisory Board2012 — 2014
Deciphera PharmaceuticalsSenior Vice-President2011 — 2012Lawrence, Kansas, United States
Jubilant BiosysSenior Vice-President, Scientific & Portfolio Strategy2010 — 2011
Pfizer Global Research and DevelopmentSenior Director2004 — 2010
Pfizer Global Research and DevelopmentDirector2003 — 2004
Pfizer Global Research and DevelopmentAssociate Director & Science Research Fellow2002 — 2003
Pfizer Global Research and DevelopmentSenior Research Advisor and Section Head2000 — 2002
Searle Discovery Research, Monsanto Life Sciences, Co.Project & Technology Leader1997 — 2000
Searle Discovery Research, Monsanto Life Sciences, Co.Senior Research Investigator1996 — 1997

Skills & more

Strategic Planning4Drug Discovery96Medicinal Chemistry64Drug Design40Drug Development58Pharmaceutical Industry37Lead Change14CRO14Oncology10LC-MS13Biotechnology27Clinical Development20

+12 more

Organic ChemistryLifesciencesPharmacologyOrganic Synthesispreclinical developmentFundraisingCapital BudgetingImmunologyRInflammationAlliance-buildingClosing Deals

From Rajesh's professional profile.

Deals · 2

Antegrin TherapeuticsBoard seat

via Atlas Venture · filed Aug 2017 · $26M raise

Euclises PharmaceuticalsBoard seat

via Atlas Venture · filed Dec 2016 · $2.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

Rectifypharma

Sources: SEC Form D filings · curated public sources.

Leave your own feedback

Colleagues at Atlas Venture

Aimee Raleigh

Principal at Atlas Venture

Aimee Raleigh, PhD

Principal at Atlas Venture

Akshay Vaishnaw, MD, PhD

Venture Partner at Atlas Venture

Alex Harding, MD, MBA

Entrepreneur-in-Residence; Chief Executive Officer, Stealth NewCo at Atlas Venture

Alex Lugovskoy, PhD

Atlas Advisor; Chief Executive Officer, Diagonal Therapeutics at Atlas Venture

Alfica Sehgal, PhD

Entrepreneur-in-Residence; Chief Scientific Officer, Judo Bio at Atlas Venture

Andrea DiMella

Senior Vice President, Head of Talent at Atlas Venture

Angela Lam

Executive Assistant at Atlas Venture

Frequently asked questions

Who is Rajesh Devraj?: Venture Partner at Atlas Venture
Where does Rajesh Devraj work?: Rajesh Devraj is Venture Partner at Atlas Venture.
What check size does Rajesh Devraj write?: Rajesh Devraj typically writes checks of $10M – $50M.
What boards does Rajesh Devraj sit on?: Rajesh Devraj holds tracked board seats at Antegrin Therapeutics, Antegrin Therapeutics, Euclises Pharmaceuticals.
What companies has Rajesh Devraj invested in?: Investments tracked here include Rectifypharma.